Article Details
Retrieved on: 2025-04-11 00:33:28
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses Sun Pharma's plan to launch Leqselvi in the US after a court lifted a prior injunction, with ongoing patent litigation against Incyte Corporation. This development impacts its stock performance on indices like BSE SENSEX and NIFTY 50.
Article found on: www.livemint.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here